PCC

This article was originally published on Cannabis.net and appears here with permission. A funny thing happened on the way to Fort Lauderdale having Biblical flooding after the Benzinga Cannabis Capital Conference in Miami, with the airport closed for 48 hours, Cannabis.net got to stick around and...

Yetter Coleman’s Matt Zorn chatted with none other than multi-awarded and great psychedelics researcher Dr. Matthew Johnson at Benzinga’s recently held Psychedelics Capital Conference. Dr. Matthew W. Johnson, Ph.D., is a Professor of Psychiatry and Behavioral Sciences at Johns Hopkins....

It's human nature to fear what we cannot understand. The best way to conquer that fear is with knowledge, Brock Pierce told the crowd at Benzinga Psychedelics Capital Conference on Thursday in Miami Beach. The crypto billionaire, economist and philanthropist who serves as...

“We are not going to be walking into a dispensary and buying DMT or ayahuasca any time soon,” said Simeon Schnapper, managing partner JLS FUND at Benzinga Psychedelics Capital Conference Thursday in Miami Beach, Florida. Comparing the cannabis and psychedelics...

Psycheceutical Bioscience (OTC: BWVI), a company focused on developing innovative technologies for the next generation of mental health treatments, recently hosted Rick Doblin, founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS), at one of its drug development...

The world of psychedelics is evolving rapidly, and the Benzinga Psychedelics Capital Conference is the premier event for those who want to be part of this exciting journey. Scheduled for April 13th, this year's edition follows the well-established Cannabis Capital Conference (CCC) and will take...

Berner, the rapper, co-founder and CEO of the cannabis and clothing brand Cookies, spoke at Benzinga's Psychedelics Capital Conference in Miami Beach in April 2022. During the conference, he talked about the genesis of Cookies and how it evolved into a multi-million dollar brand. He said that...

Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami Beach for a full day of networking and education. For those who weren't able to join us come...

Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami Beach on April 19 for a full day of networking and education. We’re happy to share a full...

Daniel Carcillo is co-founder and CEO of Wesana Health (OTC: WSNAF), a data-driven life sciences company pioneering clinical therapies and drug development through the FDA pathway. A former NHL star, Carcillo won two Stanley Cups before retiring at the age of 30 due to Post-Concussion Syndrome...

Any biotech investor knows how important catalysts are for the companies in the space. One FDA approval or denial can make or break the price of the stock.  In the psychedelic space, catalysts could be even more important, as the industry as a whole is still in its infancy.  At the...

Psyched Wellness Ltd (OTCQB: PSYCF) plans to begin selling a psychoactive mushroom extract this summer that’s never been scheduled as a drug in the U.S. It’s derived from amanita muscaria, an instantly recognizable, red-capped fungi, and its active ingredient muscimol. “Everyone...

ATAI Life Sciences NV (NASDAQ: ATAI) is deploying a multipronged approach to accelerate the development of mental health treatments.  The company operates a decentralized hub and spoke model in which each of ATAI's platform companies focuses on one lead compound in a single...

If you’re just now considering the therapeutic value of psychedelics, Cybin Inc (NYSE: CYBN) is many trips ahead of you. The Toronto-based company is studying derivatives of psilocybin and DMT and plans to file an investigational new drug application with the FDA during this quarter, CEO Doug...